Abstract Large conductance, Ca 2+ i -and voltage-gated K + (BK) channels regulate myogenic tone and, thus, arterial diameter. In smooth muscle (SM), BK channels include channel-forming α and auxiliary β1 subunits. BK β1 increases the channel's Ca 2+ sensitivity, allowing BK channels to negatively feedback on depolarization-induced Ca 2+ entry, oppose SM contraction and favor vasodilation. Thus, endothelial-independent vasodilation can be evoked though targeting of SM BK β1 by endogenous ligands, including lithocholate (LCA). Here, we investigated the expression of BK β1 across arteries of the cerebral and peripheral circulations, and the contribution of such expression to channel function and BK β1-mediated vasodilation. Data demonstrate that endothelium-independent, BK β1-mediated vasodilation by LCA is larger in coronary (CA) and basilar (BA) arteries than in anterior cerebral (ACA), middle cerebral (MCA), posterior cerebral (PCA), and mesenteric (MA) arteries, all arterial segments having a similar diameter. Thus, differential dilation occurs in extracranial arteries which are subjected to similar vascular pressure (CA vs. MA) and in arteries that irrigate different brain regions (BA vs. ACA, MCA, and PCA). SM BK channels from BA and CA displayed increased basal activity and LCA responses, indicating increased BK β1 functional presence. Indeed, in the absence of detectable changes in BK α, BA and CA myocytes showed an increased location of BK β1 in the plasmalemma/subplasmalemma. Moreover, these myocytes distinctly showed increased BK β1 messenger RNA (mRNA) levels. Supporting a major role of enhanced BK β1 transcripts in artery dilation, LCA-induced dilation of MCA transfected with BK β1 complementary DNA (cDNA) was as high as LCA-induced dilation of untransfected BA or CA.
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Introduction
Association of membrane spanning, ion channel-forming proteins with accessory subunits is an almost universal feature in membrane biology. Accessory subunits, while not contributing to ion channel pore formation itself, may drastically contribute to permeation, gating, or the pharmacological properties of the resulting channel protein heteromer. Thus, in most mammalian tissues, voltage-and Ca
2+
-gated, large conductance K + (BK) channels result from tetrameric association of channel-forming α subunits (encoded by the KCNMA1 or Slo1 gene) and regulatory β subunits [70] . These regulatory subunits are small proteins characterized by a common structural design: two transmembrane domains (TM1 and TM2) connected by an extracellular loop (ECL) that end in two short termini (N-and C-ends) [11, 12, 46, 84, 86, 89] . Four types of BK β subunits have been identified, each encoded by different genes (KCNMB1-4). Remarkably, KCNMB expression is rather tissue specific: BK β1 is highly abundant in smooth muscle whereas BK β4 is widely distributed across central neurons [7, 11, 46, 86] . This differential expression raises the possibility that modification of BK channel phenotype by BK βs is set to regulate physiology in a tissue-specific manner.
In vascular smooth muscle, association of BK β1 with slo1 increases the channel's apparent Ca 2+ sensitivity, which allows activation of BK channels at physiological negative voltages. Upon activation, BK channels generate outward K + currents that counteract depolarization-induced Ca 2+ entry and thus oppose cell contraction while favoring smooth muscle relaxation and eventual vasodilation [43, 51] . Moreover, BK β1 have been identified as critical transducers between BK channel activation and BCa 2+ sparks^, a local Ca 2+ signal generated by the activity of sarcoplasmic reticulum ryanodine receptors (RyR) [43, 51] , with Ca 2+ spark-BK channel coupling via BK β1 leading to vasodilation [12] . The rather selective expression of BK β1 in smooth muscle and the role of this subunit in regulating smooth muscle tone and vascular diameter have led to increasing efforts to determine whether important physiological signals (e.g., PIP2, leukotriene B4, estradiol, and other steroids) increase BK channel activity in smooth muscle and, thus, evoke vasodilation by interacting with BK β1 subunits (reviewed in [29] ). Our laboratory has demonstrated that the bile acid lithocholate (LCA) at micromolar levels causes artery dilation by smooth muscle BK channel activation. Moreover, this LCA action is abolished following genetic ablation of BK β1 subunits [13] . Remarkably, all other known β subunits (i.e., β2, β3, and β4) are unable to substitute for β1 in endowing the BK channel with sensitivity to micromolar LCA [16] . Thus, micromolar LCA has become a powerful pharmacological tool to test the functional presence of BK β1 subunits and BK β1 subunit-mediated, endothelium-independent vasodilation [13, 16, 19, 54] .
A differential functional expression of BK β1 across different arterial nets may lead one vascular territory and the organ/region under its perfusion to become more susceptible to modulation by endogenous signals and, thus, participate in a more or lesser degree in vascular components of pathophysiological processes (e.g., inflammation involving LTB4 or hyperdynamic states associated with portosystemic shunt of bile acids, including LCA). Likewise, such differential expression may render some vascular nets more sensitive to exogenous vasodilators that act via selective targeting of smooth muscle BK β1 subunits (e.g., HENA; [19] ). In this study, we used quantitative real-time PCR, confocal fluorescence microscopy, patch-clamp electrophysiology, in vitro electroporation, Western blotting, artery in vitro pressurization, and diameter monitoring in response to an endogenous BK β1 ligand (LCA) to demonstrate for the first time a differential functional expression of BK β1 in smooth muscle complemented with a differential response to LCA (a) between cerebral and peripheral systemic arteries (i.e., quaternary branches of mesenteric arteries (MA) and secondary branches of basilar arteries (BA)), (b) in arteries within the systemic circulation (quaternary branches of MA vs. coronary arteries (CA)), and (c) in cerebral arteries that provide blood flow to different brain regions (anterior cerebral arteries (ACA), middle cerebral arteries (MCA) and posterior cerebral arteries (PCA) vs. BA). Our study reveals that CA and BA arteries have the highest functional expression of BK β1, making them more susceptible to BK β1-mediated dilation. Moreover, we could enhance the dilation of arteries that have naturally low BK β1 function (i.e., MCA) by enriching the artery with the KCNMB1-coding complementary DNA (cDNA). Our data provide a molecular basis for the differential endothelium-independent dilation of arterial territories that irrigate different peripheral and brain targets, with practical consequences for vasodilating therapy.
Material and methods
Pressurized artery diameter measurements Adult male Sprague-Dawley rats (≈250 g) were decapitated using a guillotine. This procedure was approved by the Institutional Animal Care and Use Committee from the University of Tennessee Health Science Center (UTHSC), an AAALAC accredited institution. Rat ACA, MCA, PCA, BA (secondary branches), MA (quaternary branches), and CA were dissected on ice under a Nikon SMZ645 microscope (Nikon C-PS, Tokyo, Japan) and cut into 1 to 2 mm-long segments. A segment was cannulated at each end in a temperature-controlled, custom-made perfusion chamber. Arteries were de-endothelialized by passing an air bubble into the vessel lumen for 90 s prior to vessel cannulation. This method is highly effective for removing the endothelial layer; the absence of a functional endothelium was confirmed by the absence of vasodilation in response to an endothelium-dependent vasodilator (10 μM acetylcholine) while vasodilation in response to an endothelium-independent vasodilator (10 μM sodium nitroprusside) was preserved [13, 15, 18, 20, 58] .
Using a Dynamax RP-1 peristaltic pump (Rainin Instr., Columbus, OH), the chamber was continuously perfused at a rate of 3.75 ml/min with physiologic saline solution (PSS) (mM): 119 NaCl, 4.7 KCl, 1.2 KH 2 PO 4 , 1.6 CaCl 2 , 1.2 MgSO 4 , 0.023 EDTA, 11 glucose, and 24 NaHCO 3 . PSS was equilibrated at pH 7.4 with a 21/5/74% mix of O 2 /CO 2 / N 2 and maintained at 35-37°C. Arteries were monitored with a CCD camera (Sanyo VCB-3512T; Sanyo, Osaka Prefecture, Japan) attached to an inverted microscope (Nikon Eclipse TS100; Nikon, Tokyo, Japan). As routinely done by us [13, 18-20, 22, 58] and others [2, 4, 6, 10, 34, 35, 80] , the artery external wall diameter (ED) was measured using the automatic edge-detection function of the IonWizard software (IonOptix, Westwood, MA) and digitized at 1 Hz. Steady-state changes in intravascular pressure were achieved by elevating an attached reservoir filled with PSS and were monitored using a pressure transducer (Living Systems Instrumentation, St Albans City, VT). Arteries were first incubated at an intravascular pressure of 10 mmHg for 10 min. Then, intravascular pressure was increased to 60 mmHg and held steady throughout the experiment to allow arteries to develop and maintain myogenic tone. Drugs were dissolved to make stock solutions, diluted in PSS to final concentration, and applied to the artery via chamber perfusion. The effect of drug application on artery ED was evaluated at the time ED reached a maximal, steady level.
Isolation of rat artery myocytes Individual myocytes were enzymatically isolated from ACA, MCA, PCA, BA, MA, or CA arterial rings (see previous section) following a procedure described in detail elsewhere [15, 18, 30, 58] . The procedure rendered a cell suspension containing relaxed, individual myocytes (≥5 myocytes/field using a 20× objective) that could be identified under an Olympus IX-70 microscope (Olympus America, Center Valley, PA). The cell suspension was stored in ice, and the cells were used for patch-clamp recordings and fluorescence labeling up to 3 h after isolation.
Electrophysiology experiments on BK channels in arterial smooth muscle cells To measure the basal activity of smooth muscle BK channels in arteries from different territories, single-channel BK currents were recorded from excised, inside-out (I/O) membrane patches at 3 μM free Ca [28] . Patch-recording glass electrodes were prepared as described elsewhere [31] . Immediately before recording, the tip of each electrode was fire polished on a WPI MF200 microforge (World Precision Instruments, Sarasota, FL) to give resistances of 2-5 MΩ when filled with electrode solution. An agar bridge with Cl − as the main anion was used as ground electrode. Data were acquired using an EPC8 amplifier (HEKA Electronics, Lambrecht, Germany), low passed at 1 kHz using an eight-pole Bessel filter (Frequency Devices, Ottawa, IL), and digitized at 5 kHz using a Digidata 1320A A/D converter and pCLAMP 8.0 (Molecular Devices, Sunnyvale, CA).
After excision of the membrane patch from the cell, the patch was consecutively exposed to a stream of bath solution containing 0.1% (v/v) DMSO (i.e., control solution), then bath solution containing 45 μM LCA followed by the patch exposure to control solution to wash LCA out. Solutions were applied onto the patches using a computerized and pressurized DAD12 system (ALA Scientific Instruments, Farmingdale, NY) via a micropipette tip with an internal diameter of 100 μm. Experiments were carried out at room temperature (21°C).
Immunocytochemistry and confocal fluorescence imaging
Freshly dispersed myocytes were first allowed to settle/attach on a coverslip on ice for 30 min. Then, they were fixed in 4% paraformaldehyde for 10 min. Fixed myocytes were permeabilized with 0.1% Triton X-100 for 10 min and then incubated with blocking solution containing 20% goat serum and 2% bovine serum albumin for 30 min. The coverslips were then incubated with mouse monoclonal anti-slo1 subunit antibody (NeuroMab, UC Davis) and rabbit polyclonal anti-BK β1 subunit antibody (Thermo Scientific, Waltham, MA) at 4°C overnight. Then, cells were washed with phosphate-buffered saline (PBS) and incubated with preabsorbed Alexa Fluor 488-conjugated anti-mouse and Cy5-conjugated anti-rabbit secondary antibodies at room temperature in the dark for 2 h. Coverslips were mounted on slides using ProLong Antifade Kit (Invitrogen, Carlsbad, CA) and sealed using clear nail polish. Immunofluorescence images were obtained sequentially using the 488 and 635 laser lines of an Olympus FV-1000 laser scanning confocal system (Olympus American Inc., Center Valley, PA). Laser power, photomultiplier tube gain, and offset parameters were identical in all experiments.
Western blotting Western blotting was performed as described in detail elsewhere [49, 50] .
Quantitation of BK β1 subunit mRNAs in rat arteries Total RNA was extracted from de-endothelialized rat arteries using TRIzol (Life Technologies, Carlsbad, CA, USA) as described elsewhere [25] . Reverse transcription was conducted from 1 μg of total RNA using the Transcriptor First Strand cDNA Synthesis Kit (Roche, Basel, Switzerland) following the manufacturer's instructions. BK β1 transcript levels were determined by quantitative real-time PCR. Quantitative realtime PCR was performed in 96-well plates with a LightCycler 480 (Roche, Basel, Switzerland) using the LightCycler 480 master mix and a Universal Probe Library (UPL) probe (Roche, Basel, Switzerland) at a concentration of 10 μM in a final reaction volume of 10 μl under the following conditions: 95°C for 5 min for activation and 45 cycles of 95°C for 10 s, 60°C for 60 s, and 72°C for 10 s for amplification. Negative controls without cDNA were run for each reaction. After testing six endogenous control genes, TATA binding protein (TBP) was used as an endogenous control gene. Sequences of primers and relevant probes for BK β1, and TBP are shown in Table 1 . All samples were analyzed in triplicate. Relative messenger RNA (mRNA) levels were normalized to TBP mRNA levels obtained from the same sample of cDNA. Expression of BK β1 relative to TBP in each sample was calculated on the basis of the ΔΔC T method (where C T is threshold cycle), as previously described [59] . Gene-specific primers and probes were designed using the Universal Probe Library (UPL; http://www.roche-appliedcience.com/sis/rtpcr/upl/index.jsp). These experiments were conducted at the UTHSC Molecular Resource Center.
Electroporation of cerebral arteries In order to overexpress BK β1 in MCA, these arteries were placed into an electroporation chamber (pulse generator model CUY21 Vitro-EX; BEX CO., LTD., Itabashiku, Tokyo) at room temperature in Ca 2+ -free PBS containing 15 μg of either empty vector (pcDNA3) or pcDNA3-β1 (pcDNA3 containing the β1 insert). Tandem pulse electroporation was applied to the arteries. Then, arteries were removed from the chamber and maintained in PBS containing either empty vector or BK-β1 for 10-15 min before being placed in PBS for an additional 15 min. The transfected arteries were then placed in DMEM/F12 media (serum free) supplemented with 1% penicillin-streptomycin (Sigma-Aldrich, St. Louis, MO) for 3-4 days under standard conditions (5% CO 2 ; 37°C). Arteries transfected with either empty vector or BK β1 were then used for experimentation: Western blotting or pressurized artery diameter measurement.
Chemicals Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich (St. Louis, MO). Just before the experiment, LCA was initially dissolved in DMSO to obtain a stock solution of 33 mM. Stock solution was sonicated for 30 min. Then, to obtain final LCA concentration (45 μM), the stock solution was further diluted with PSS.
Data analysis Artery diameter data were analyzed using the IonWizard 4.4 software (IonOptix, Westwood, MA). The Barterial diameter before drug application^was obtained by averaging ED values recorded for 5 min immediately before drug application. A drug-induced change in arterial ED was determined from the peak effect obtained during drug application. For patch-clamp recordings at single-channel resolution, the product of the number of channels in the patch (N) and the channel individual open probability (P o ) was used as an index of channel steady-state activity. Using a built-in function in Clampfit 9.2 (Molecular Devices), NP o was calculated from at least 30 s of gap-free recordings under each experimental condition.
Fluorescence was quantified using built-in function in the FV10-ASW 3.1 software (Olympus American Inc., Center Valley, PA) as described in [20] . The fluorescence corresponding to the plasmalemma-subplasmalemma region was obtained following direct superposition of the myocyte fluorescent image with the corresponding image of the myocyte under visible light. Fluorescence was quantified by measuring the intensity of pixels above a set threshold defined as the mean fluorescence intensity outside the cells (i.e., background).
Data are expressed as mean ± SEM (n = number of patches/ arteries) and plotted and fitted using Origin 8.5 (OriginLab, Northampton, MA) and InStat3 (GraphPad, La Jolla, CA).
Results
Effect of in vitro lithocholate exposure on diameter from deendothelialized cerebral, mesenteric, and coronary arteries Our group has previously reported that LCA dilates rat MCA in an endothelium-independent fashion [13, 19] . Thus, we first determined the effect of 45 μM LCA on de-endothelialized ACA, PCA, BA, MA, and CA, using de-endothelialized MCA as our Bpositive control^. The LCA concentration chosen constitutes EC 50 for LCA to activate smooth muscle BK channels and thus increase MCA diameter [13] . This LCA concentration can also be found in systemic blood following spillover from the portal to the systemic circulation under several pathological conditions [37, 41, 55, 81] . After development of myogenic tone, maximal artery contraction was determined by perfusing the vessel with 60 mM KCl. At the end of each experiment, the artery was exposed to a Ca 2+ -free solution for determination of passive diameter (Fig. 1a) . Treatment with control (DMSO containing) solution (composition in BMaterial and methods^) did not produce significant change in the diameter of any of the arteries tested, as representatively shown with MCA (Fig. 1a) . In contrast, 45 μM LCA increased ED in all cases (p < 0.05), averaging 3.5 ± 0.46, 4.59 ± 0.8, 4.6 ± 1.08, 12.9 ± 1.8, 4.4 ± 0.6, and 10.4 ± 0.5% increase over pre-LCA values for ACA, MCA, PCA, BA, MA, and CA, respectively (Fig. 1b) . These results document a significantly different response to LCA from arteries that (1) belong to cerebral vs. systemic circulation (e.g., MCA vs. CA), (2) belong to systemic circulation (e.g., CA vs. MA), and (3) branch out from the Willis' circle itself (e.g., ACA/MCA/PCA vs. BA). Our data were obtained in de-endothelialized arteries under continuous bath perfusion, which results in the wash out of freely diffusible signaling molecules. Moreover, smooth muscle accounts for ≥52% of the total vessel wall in cerebral arteries [52] . Thus, it is possible to hypothesize that the differential endothelium-independent vasodilation evoked by LCA on the different arteries probed in our study is mediated by targets and mechanisms that operate within the vascular smooth muscle myocyte. BK channels in myocytes from basilar and coronary artery are highly sensitive to lithocholate Previous studies [13] on rat MCA demonstrate that LCA-induced artery dilation is due to steroid action on the arterial myocyte itself. Furthermore, we found that LCA-mediated MCA dilation was mediated by LCA activation of vascular smooth muscle BK channels [13] . Thus, we hypothesize that vascular smooth muscle BK channels isolated from arteries that presented a differential vasodilating response to LCA (Fig. 1 ) are differentially activated by LCA at concentrations that evoke vasodilation. To test this hypothesis, we evaluated LCA action on BK channel steady-state activity (i.e., the product of N × P o , see BMaterial and methods^) by using I/O patch-clamp recordings in myocytes freshly isolated from ACA, MCA, PCA, BA, MA, and CA. In all cases, the membrane potential was set to −40 mV and free [Ca 2+ ] i to 3 μM: these conditions reproduce the transmembrane voltage and intracellular Ca 2+ i level found in the vicinity of the BK channel during myocyte contraction, that is, when BK channels exert a physiological negative feedback on depolarization-induced arterial myocyte contraction [47, 75] . Paralleling the drug application protocol used with the arterial segments in artery diameter determination experiments (see above), each excised patch was sequentially exposed to vehicle-containing (control), LCA-containing (45 μM final concentration), and vehicle-containing solution (LCA washout) ( Fig. 2a-f) . Application of LCA reversibly increased BK NP o by 3.5 ± 1.1, 3.6 ± 1.1, 5.5 ± 1.6, and 3.5 ± 1.1 times of pre-LCA levels in myocyte membrane patches from ACA, MCA, PCA, and MA arteries, respectively (Figs. 2 and 3a) (p < 0.05). Remarkably, LCA increased BK NP o approximately 14.01 ± 2.7 and 11 ± 1.9 times when compared to pre-LCA values in myocytes from BA and CA, respectively (Figs. 2 and 3a) (p < 0.05). This LCA action is significantly larger than LCA-induced BK channel activation in ACA, MCA, PCA, and MA myocytes (p < 0.05). Moreover, the overall differential sensitivity to LCA of smooth muscle BK channels across the arteries under study highly correlates with the sensitivity of the different arteries to LCA-induced, endothelium-independent vasodilation (Pearson's r = 0.9898; degrees of freedom = 4; Fig. 3b ). This extremely high positive correlation, together with previous data establishing that LCA-induced dilation of MCA is due to LCA activation of smooth muscle BK channels [13] , strongly suggests that the larger LCA-induced BK channel activation in myocytes of BA or CAvs. that of ACA, MCA, PCA, or MA, is an important contributor to the larger LCA-induced dilation of the former group of arteries vs. the latter.
BK channel steady-state activity is higher in myocytes from basilar and coronary arteries Lithocholate-induced dilation of MCA is mediated by the activation of smooth muscle BK channels via direct and selective LCA-β1 subunit interaction [13, 14, 17] . On the other hand, it is widely accepted that within physiological levels of Ca 2+ i and voltage, overexpression of β1 subunits with slo1 in heterologous systems (HEK293 cells, Xenopus laevis oocytes) leads to increased BK steady-state activity [5, 11, 27, 49, 50] . The stoichiometry of slo1 and β1 subunits in native channels across different vascular and non-vascular tissues remains largely unknown. Conceivably, in some arterial myocytes, β1 subunits do not saturate their BK channel-forming slo1 counterparts. Thus, the differential LCA sensitivity of BK channels across the different arteries may be the result of heterogeneous channel composition, i.e., the more sensitive channels may reside in arterial myocytes that have higher β1 expression. It is also possible, however, that a different proteolipid composition across different arteries leads to differential functional Fig. 1 Dilatation by lithocholate, a BK β1 ligand, is highest in basilar and coronary arteries. a Representative arterial diameter trace from rat MCA pressurized in vitro. After development of myogenic tone, the artery was probed with 60 mM KCl to test maximal contraction. After KCl washout, the artery chamber was perfused with PSS that contained vehicle (DMSO, 0.1% v/v). Then, artery was probed with 45 μM LCA, which constitutes EC 50 for LCA activation of β1-containing BK channels [13] . Vertical lines underscore the beginning of perfusion with any given
solution. The shadowed area shows the AUC corresponding vasodilation by LCA, which is fully reversible. An identical protocol was used with ACA, PCA, BA, MA, and CA. b Bar graph demonstrating that LCAinduced dilation of BA and CA is drastically larger that evoked on ACA, MCA, PCA, or MA; n = 3-7, *different from BA, p < 0.05. ACA anterior cerebral artery, MCA middle cerebral artery, PCA posterior cerebral artery, BA basilar artery, MA mesenteric artery, CA coronary artery, LCA lithocholate coupling between slo1 and β1 (see BDiscussion^). This, in turn, could contribute to a regionally distinct BK channel-LCA interaction, which leads to a differential channel response to the steroid. In either case, the resulting end point would be an increased basal (i.e., before LCA application) BK activity in the arterial myocytes that display the greater sensitivity to LCA. Thus, we next hypothesized that myocytes from BA and CA, which displayed increased responses to LCA when compared to their ACA, MCA, PCA, and MA counterparts (Figs. 2 and 3 (Fig. 4a) (Fig. 4b) . These data clearly demonstrate that BK channel steady-state activity in myocytes from BA and CA is significantly higher (p < 0.05) than BK activity in myocytes from other arteries. Furthermore, the parallel leftward shift in the NP o /NP o max -V curve seen at physiological Ca 2+ i is consistent with an increased presence of functional BK β1 subunits [5, 11, 27, 49, 50, 66, 69] . Interestingly, the actual BK V half values in myocytes from BA and CA are similar to those found using heterologous expression systems in which overexpression of β1 subunits is considered to saturate their slo1 partners, including slo1 cloned from rat cerebral artery myocytes ( [5, 11, 27, 49, 50, 69] ; e.g., at physiological 3 μM Ca 2+ i , V half values for BA, CA, and slo1 + β1 overexpressed in oocytes are 23.5 ± 5.9, 25.15 ± 3.4, and 24.7 ± 13.0 [27] ) respectively. Collectively, our electrophysiological data strongly suggest that the increased activity of myocyte BK channels in CA and BA is primarily due to an increased functional presence of BK β1 in these arteries.
Cell surface levels of BK β1 protein are higher in basilar and coronary artery smooth muscle cells Although BK channels have been found in internal organelles, such as mitochondria and the nuclear envelope [56, 78, 79] , BK channels located in the plasmalemma primarily control myogenic tone and, most likely, its modulation by LCA [13, 74, 75] . Therefore, the simplest explanation for increased myocyte BK function and vasodilation via β1 subunits in BA and CA is that these modulatory proteins are expressed in the plasma membrane of myocytes in BA and CA at levels significantly higher than those found in myocytes from ACA, MCA, PCA, and MA. To test this, we first used immunofluorescence staining of BK α and β1 subunits in myocytes freshly isolated from ACA, MCA, PCA, BA, MA, and CA. Data failed to reveal significant differences in BK α subunit-associated fluorescence across the different arteries (Figs. 5a and 6a ). In contrast, BK β1 subunit-associated fluorescence was significantly increased in myocytes from BA and CA when compared to that from ACA, MCA, PCA, or MA (Figs. 5b and 6b). Conceivably, an increased surface presence of BK β1 protein in myocytes from BA and CA is a main determinant of the hyperpolarized V half values characteristic of BK current in myocytes from these arteries (Fig. 4b) , as well as the increased BK channel activation and arterial dilation in response to LCA, a BK β1-ligand (see BDiscussion^).
KCNMB1 gene expression studies in different vascular territories To begin to explore the mechanisms underlying a differential membrane surface expression of BK β1 proteins in myocytes from different arterial territories, we considered the possibility of a differential content of BK β1 transcripts across the arteries under study. To test for this possibility, we measured levels of BK β1 mRNA across de-endothelialized ACA, MCA, PCA, BA, MA, and CA using quantitative, real-time PCR. Results demonstrate that BK β1 mRNA levels were significantly higher in BA and CA vs. those present in all other arteries (Fig. 7) . Thus, it is highly likely that the increased BK β1 mRNA levels are a primary determinant of the increased BK β1 protein levels found in the plasmalemma of BA and CA myocytes (Figs. 5 and 6 ), an idea that we test in the following sections.
Overexpression of BK β1 subunit in middle cerebral artery enhances the artery's sensitivity to lithocholate that acts via BK β1 So far, our collective data indicate that BA and CA are characterized by an increased vasodilatory response to LCA, a β1-dependent BK channel activator, with these arteries being characterized by (a) increased LCA response and (b) basal activity of myocyte BK channels, (c) increased myocyte surface expression of BK β1 subunits, (Figs. 4, 5 , and 6), and BK β1 mRNA levels ( Fig. 7 ) when compared to those of BA or CA; (2) rat MCA is a widely used experimental model to address human cerebrovascular pathophysiology and pharmacology [3, 26, 33, 87] ; and (3) we conducted all our previous studies with smooth muscle BK β1-targeting vasodilators (LCA itself, other cholanes, LTB4, and HENA) using rat MCA [13, 14, 17, 19, 62, 73] . BK β1 protein overexpression was confirmed by Western blotting (Fig. 8a) . First, arteries that were transfected with BK β1
cDNA contained significantly higher levels of BK β1 subunit protein than those of control arteries, i.e., transfected with an Bempty^vector (Fig. 8b) , underscoring the efficiency of our electroporation procedure. Second, functional studies on pressurized arteries demonstrated that in vitro electroporation, either with empty vector (pcDNA3 alone) or with β1 (KCNMB1) cDNA, preserved the contractile and dilatory responses evoked by 60 mM K + -and Ca 2+ -free bath solution, respectively (Fig. 8c, d ). These data underscore that the electroporation procedure did not disrupt maximal contractile/dilatory function of the artery. Third, application of 45 μM LCA to MCA transfected with empty vector resulted in 5.83 ± 0.4% increase in artery diameter from pre-LCA application level (Fig. 8c, e) . This LCA response is similar to that evoked in untransfected MCA (Fig. 8e ) and in [13] . Finally, and more importantly, MCA transfected with BK β1 cDNA responded to LCA application with a dilation that reached 10.6 ± 0.45%, i.e., significantly higher (p < 0.05) than the dilation of arteries transfected with empty vector or the dilation of untransfected arteries (Fig. 8e) . Last but not least, the LCA-induced dilation of MCA transfected with BK β1 cDNA is similar to LCA-induced dilation of arteries that naturally expresses higher levels of BK β1 (i.e., BA and CA) (Fig. 1b) . These data clearly demonstrate that overexpression of BK β1 mRNA and, thus, BK β1 protein levels can improve the vasodilatory response of arteries to BK β1-dependent vasodilators.
Discussion
Using a combination of quantitative real-time PCR, Western blotting, laser confocal fluorescence microscopy, single-channel resolution patch-clamp electrophysiology, in vitro electroporation, and artery pressurization in vitro, we demonstrate that arteries from the peripheral (e.g., quaternary branches of MA), coronary, and cerebral (ACA, MCA, PCA, and secondary branches of BA) circulations differ in their dilatory response to a selective BK β1-targeting vasodilator (LCA). Furthermore, our study reports a differential endothelium-independent vasodilation to LCA across the distribution arteries that stem out of the Willis' circle, with BA having a response to LCA that is drastically higher than those of ACA, MCA, and PCA (Fig. 1b) . Biochemical, confocal imaging, and electrophysiological data indicate that the arteries with higher responses to LCA, that is CA and BA, also display (1) enhanced activation of smooth muscle BK channels to this rather selective BK β1 agonist (Figs. 2 and 3) , (2) increased functional presence of BK β1 subunits in the native smooth muscle BK channel (Fig. 4) , (3) increased immunofluorescence for BK β1 subunit protein in the myocyte plasmalemma-subplasmalemma region (Figs. 5 and 6), and (4) significantly higher levels of BK β1 mRNA in cerebral smooth muscle (Fig. 7) . All these functional and biochemical differences reflecting a differential BK β1 subunit functional presence across different vessels seem rather selective, as they are not accompanied by detectable changes in expression, membrane location, or mRNA levels of the BK channel-forming α subunit. Conceivably, the increase in mRNA BK β1 transcript in vascular smooth muscle is the major mechanism leading to enhanced smooth muscle BK channel function and eventual increased dilation of BA and CA in response to a selective BK β1-targeting physiological agent. Indeed, our study proves that transfecting BK-β1 coding cDNA into MCA, an artery that has much lower levels of BK β1 and LCA-invoked dilation when compared to CA or BA, increases the dilatory of MCA to levels similar to those of CA and BA (Fig. 8) .
A previous study using rats has documented a higher functional expression of BK β1 in cerebral artery (territory unspecified) arterioles vs. primary and secondary branches of cremaster artery [90] . Likewise, smooth muscle BK channels in C57/BL6 mouse cerebral arteries show a higher functional presence of BK β1 when compared to pulmonary artery myocytes [93] . Notably, these two studies evaluated smooth muscle BK channels in arterial segments that greatly differ in diameter and/or function: mouse cerebral arteries have a diameter of ∼100 μm and serve as resistance vessels whereas their pulmonary counterparts have a diameter of ∼800 μm and serve as conduit vessels [93] . Rat MCA main branches and first-order cremaster arterioles also greatly differ in diameter: ∼284 and 168 μm (passive diameter), respectively [42] . Our data, however, document that differences in functional BK β1 presence in smooth muscle from different territories can be observed across arteries that (a) were specifically selected to fall within a similar diameter range (175-230 μm). Indeed, secondary and quaternary branches of BA and MA, respectively, were dissected whereas primary branches of ACA, MCA, and PCA were chosen (i.e., ACA: 210.97 ± 13.69 μm; MCA: 174.73 ± 11.29 μm; PCA: 193.08 ± 17.08 μm; BA: 179.08 ± 23.79 μm; MA: 229.83 ± 25.04 μm; CA: 223.22 ± 29.52 μm); (b) are exposed to similar levels and variations in systemic arterial pressure, i.e., CA vs. MA quaternary branches; or (c) fulfill an equivalent function, i.e., primary blood distribution branching out of the Willis' circle, i.e., BA vs. ACA, MCA, and PCA. Remarkably, our study reveals that the arteries with higher functional BK β1 expression irrigate vital organs: CA provides blood to the myocardium while BA, together with vertebral arteries, to the brain stem [24, 38, 52] , which includes cardio-respiratory centers essential for life. Since BK β1 subunits are not found in invertebrates, such as Drosophila melanogaster or Caenorhabditis elegans [23, 70, 94] , it is tempting to speculate that the high functional expression of BK β1 subunit in rat CA and BA smooth muscle could be indicative of an enhanced protection against vasoconstriction in organs and brain regions that are vital to more evolutionary advanced organisms, including mammals.
The increased functional presence of BK β1 subunits in the smooth muscle of rat CA and BA when compared to other arterial territories is evident from the leftward shift in the NP o /NP o -V plots with the resulting decrease in V half (Fig. 4a, b) and the increased response to 45 μM LCA (Figs. 2 and 3) , that is, a concentration that requires the presence of functional β1 subunits in the smooth muscle BK channel complex for LCA to increase channel activity and thus evoke endothelium-independent MCA dilation in both rat and mouse [13] . A similar combination of patch-clamp electrophysiology and pharmacological profiling (i.e., application of 17β-estradiol) was previously used to conclude that cerebral artery BK channels contain functional levels of β1 subunits higher than those found in the cremaster arteries. Consistently, Western blotting results have shown higher levels of BK β1 protein in the cerebral arteries [90] . Our laser confocal microscopy data further document that, when compared to myocytes from other arteries, the increased functional presence of BK β1 subunits in myocytes from BA and CA is associated with increased levels of this subunit in the myocyte plasmalemma-subplasmalemma, in absence of detectable changes in α subunit location or expression.
Several non-mutually exclusive mechanisms may account for the increased presence of BK β1 subunits in myocytes of CA and BA arteries, including increased subunit shuttling from the endoplasmic reticulum-Golgi to the plasmalemma, decreased endocytosis and degradation, and increased gene expression. While changes in BK β1 subunit between the cell membrane and internal compartments [54] cannot be ruled out, the fact that CA and BA present drastically higher levels of cDNA coding for BK β1 (Fig. 7) supports the idea that the increased BK β1 protein in the membrane of CA or BA myocytes is driven by increased levels in BK β1 mRNA transcripts. Consistent with this hypothesis, the LCA-induced dilation of MCA (which shows lower cDNA β1 levels than those of BA or CA; Fig. 7 ) transfected with BK β1 cDNA is similar to the dilation of arteries that naturally express higher levels of BK β1 (i.e., BA and CA) (Fig. 8d, e) .
It was initially thought that the stoichiometry of assembly of α and β1 subunits is 1:1 [46] , resulting in a heterooctameric protein complex (i.e., 4α/4β1). Using recombinant α and β1 subunits expressed in X. laevis oocytes, however, it has been demonstrated that functional channels may include a variant number of β1 subunits. Moreover, each individual β1 subunit inserted in the channel complex produces an essentially identical, incremental effect on channel gating and, thus, availability for activation [88] . These authors reported that four different α/β1 molar ratios (reflecting stoichiometries between 4α/≤1β1 and 4α/4β1) rendered four distinct current phenotypes independently of the α subunit used. Conceivably, the reduced activity and LCA responses of myocyte BK channels from ACA, MCA, PCA, and MA may be determined by channel complexes that are unsaturated with β1 proteins, with the 4α/4β1 stoichiometry being predominant in myocyte BK channels from BA, from CA, and from MCA transfected with β1 BK cDNA. Disregarding the stoichiometric underpinnings that may contribute to the increased activity and LCA responses of myocyte BK channels from CA and BA, our results clearly indicate that basal activity and the pharmacological response of vascular smooth muscle BK channels can be substantially regulated by manipulating the expression of the BK β1 subunits.
While presenting some regional variations, the major cerebral arteries of rats and humans share strong similarities in overall organization, vessel structure, and morphological changes driven by cerebrovascular disease [36, 52] . Thus, our current findings may have wide pathophysiological and health-related implications, as follows. Consistent with previous reports [13, 19] , our study shows that 45 μM LCA evokes an increase in MCA diameter of 4.59 ± 0.85%. In contrast, this LCA concentration resulted in a 12.98 ± 1.5% increase in BA diameter (Fig. 1b) . Poiseuille's law has established that fluid flow is a function of the fourth power of the vessel radius. Thus, LCA-induced vasodilation should result in a robust increase in cerebral blood flow: about +19.7% and +63% for territories irrigated by MCA and BA, respectively. Under physiological conditions, LCA in particular and bile acids in general barely reach 2-3 μM in systemic (including cerebral) circulation [21, 39, 40, 76] . However, many human pathological conditions including liver cirrhosis [44, 45, 57] , chronic active hepatitis [48] , extrahepatic cholestasis [57] , and the stagnant loop syndrome [55] are associated with abnormal levels of bile acids in systemic blood due to spillover of bile acids from the portal to the systemic circulation [37, 41, 55, 81] . Such spillover results in a 10-100-fold higher systemic bile acid concentration [21, 37, 71] . These abnormal levels of bile acids are responsible for the systemic hypotension observed in patients with liver damage and/or significant portosystemic circulatory shunt [9] . Moreover, several experimental models have demonstrated that bile acids evoke vasodilation in an endothelium-independent manner, attenuate vascular reactivity in vitro, and reduce systemic blood pressure in vivo [8, 13, 72] . Our previous studies have shown that the dilation of rat and mouse MCA by bile acids, LCA in particular, is mediated by a direct interaction between LCA and the BK channel β1 protein [13, 14, 16, 17] . Our current data suggest that territories irrigated by the vertebro-basilar system, such as the medulla, cerebellum, pons, midbrain, thalamus, and occipital cortex, which control heart rate, respiration, gait and equilibrium, audition, memory, and sleep cycling would be the most affected by arterial dilation in response to micromolar levels of circulating bile acids. Bile acids have been increasingly recognized as major pathophysiological players in neurological disease (reviewed in [63] ). An arterial contribution to such bile acid role, however, remains to be studied.
In turn, LCA synthetic analogs that selectively target BK smooth muscle β1 subunits have been developed in the hope of obtaining cerebral vasodilators that remain effective independently of intact endothelial function and lack side effects related to steroidal nucleus recognition [19] . The need for such development is compounded by the facts that (a) biomedical research has largely failed to produce effective, easy to use, cerebral vasodilators [53] ; and (b) endothelial-mediated vasodilation is impaired in various conditions associated with cerebrovascular ischemia, such as atherosclerosis. Our current data suggest that such BK β1-targeting smooth muscle relaxants (e.g., HENA; [19] ) would be more effective in evoking dilation of the vertebro-basilar system than of ACA, PCA, or MCA. The use of HENA or other LCA-related agents that evoke endothelium-independent dilation, however, should be hampered under conditions where the functional presence of BK β1 subunits is diminished. For instance, downregulation of these subunits has been reported in rats subject to angiotensin-induced hypertension [1] , streptozocin-induced diabetic hypertension [61, 91, 92] , and even with ageing [60, 68, 82] . Interestingly, it has been reported that NO· and other smooth muscle relaxants dilate cerebral arteries by altering the shuttling of BK β1 subunits with eventual increased location of these subunits in the myocyte plasmalemma [54] . Then, NO·-delivering agents and HENA-like agents might constitute an attractive combination to evoke cerebral dilation under the aforementioned conditions associated with reduced amount of BK β1 subunits.
Our present results also suggest that in peripheral circulation, BK β1-targeting vasodilators, whether endogenous or exogenous, would be more effective on CA than on MA arteries. Interestingly, 17β-estradiol has been reported to increase BK channel function and, thus, relax vascular smooth muscle, via several mechanisms, including a direct interaction with BK β1 subunits [83, 85] . Thus, it is possible to speculate that CA relaxation as a result of 17β-estradiol-BK β1 direct interaction could be particularly effective to protect the myocardium against ischemia.
Finally, previous studies found that a polymorphism (E65K) in KCNMB1 resulted in a gain-of-function BK channel, such polymorphism being associated with protection against moderate-to-severe diastolic hypertension. The E65K substitution in BK β1 subunits resulted in heteromeric channels that show an increased Ca 2+ sensitivity, which would result in a more efficient negative feedback on vascular smooth muscle contractility [32] . Considering the highest level of β1 subunits in CA compared to most other vascular beds (Figs. 5 and 6), it can be hypothesized that CA would be particularly susceptible to such polymorphism. Interestingly, E65K carriers in the older female population show a drastically reduced occurrence of myocardial infarction when compared to non-carriers [77] .
In synthesis, we have demonstrated that BK β1 subunits show marked differences in both gene and protein expression across intracranial (ACA, MCA, and PCA vs. BA) and peripheral (CA vs. MA) vessels, with CA and BA showing the highest levels. Further, these differences in transcript and protein levels translate into higher basal BK channel activity as well as increased channel activation and vasodilatory responses to an endogenous BK β1-selective agonist. Thus, our study buttresses the notion that BK β1 subunits exhibit a different functional presence across arterial territories, which can explain differential local responses to endogenous and exogenous vasodilators, and may provide a molecular basis for regional susceptibility to vascular disease.
